Learn About Advances in Liver Disease on CME Webcast. On this CME webcast, we’re going to hear about the latest chapter in the hepatitis C saga, that is, the treatment of hepatitis C. And we’re also going to hear about some of the other emerging liver diseases that you are likely to encounter in your clinical practice and some of the tools hepatologists use to evaluate liver conditions. Let me welcome today’s guests, both hepatologists from the Ohio State University. Dr. James Hanje is an Associate Professor of Internal Medicine and Dr. Anthony Michaels is also an Associate Professor of Internal Medicine.
View a video introduction of this webcast
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: Recognize the change in patient population in patients with chronic liver disease; Describe the problem of frailty; Review
methods of Hepatitis C diagnosis and staging; and Review current therapeutic Hepatitis C treatment options.
You’ll also learn about the following:
- Causes of liver disease in the United States
- Hepatitis C
- The economics of treating hepatitis C
- Transmission of hepatitis C
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at firstname.lastname@example.org.